First US Gene Therapy, Approved for Vision Loss, to Cost $850000 – Xconomy
Xconomy |
First US Gene Therapy, Approved for Vision Loss, to Cost $850000
Xconomy The first gene therapy approved in the United States will cost $850,000, its developer Spark Therapeutics (NASDAQ: ONCE) announced today. Spark hopes to reduce the sticker shock by offering refunds and other creative pricing ideas, but those carve-outs … |
